IDH1 and glioblastoma: These findings suggest that, given the prevalence of these 6 gene mutations, following the diagnosis of glioblastoma and knowledge of IDH1/2 mutation status, GTR (or maximum safe resection) should be attempted on all patients regardless of results from sequencing studies.